In coordination with Member States, the World Health Organization (WHO) and partners have established an access and allocation mechanism for mpox medical countermeasures including vaccines, treatments and diagnostic tests.
Evotec and Novo Nordisk launch LAB eN² to accelerate translation in cardiometabolic diseases – Biotech Investments
EQS-News: Evotec SE / Key word(s): Miscellaneous Evotec and Novo Nordisk launch LAB eN² to accelerate translation in cardiometabolic diseases 26.09.2023 / 13:35 CET/CEST The